MediciNova (TSE:4875) Total Liabilities: 円523.34 Mil (As of Mar. 2026)


TSE:4875 MediciNova Inc TSE:4875
28 GF Score
Price 円213.00
! 2 Warning Signs
View Full Analysis

What is MediciNova Total Liabilities?

MediciNova TSE:4875 +1.91% 28 Total Liabilities is 円523.34 Mil as of Mar. 2026. GuruFocus rates TSE:4875 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

MediciNova's Total Liabilities for the quarter that ended in Mar. 2026 was 円523.34 Mil.

MediciNova's quarterly Total Liabilities increased from Sep. 2025 (円534.38 Mil) to Dec. 2025 (円626.16 Mil) but then declined from Dec. 2025 (円626.16 Mil) to Mar. 2026 (円523.34 Mil).

MediciNova's annual Total Liabilities declined from Dec. 2023 (円560.38 Mil) to Dec. 2024 (円518.66 Mil) but then increased from Dec. 2024 (円518.66 Mil) to Dec. 2025 (円626.16 Mil).

MediciNova Total Liabilities Historical Data

* Premium members only.

The historical data trend for MediciNova's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediciNova Total Liabilities Chart

MediciNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 424.48 527.92 560.38 518.66 626.16

MediciNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 372.79 428.68 534.38 626.16 523.34
TSE:4875
28GF Score
MediciNova Inc TSE:4875
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediciNova Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MediciNova's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=592.165+(0+2.495
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+31.495+0+0)
=626.16

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=7110.192-6484.037
=626.16

MediciNova's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=491.282+(0+2.8421709430404E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+32.054+0+0)
=523.34

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=6776.545-6253.209
=523.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円523.34 Mil mean?
MediciNova (TSE:4875) has a Total Liabilities of 円523.34 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MediciNova and its competitors.
Is MediciNova's Total Liabilities too high?
MediciNova's current Total Liabilities is 円523.34 Mil. Overall, MediciNova has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does MediciNova's Total Liabilities compare to TCRX and PMVP?
MediciNova's Total Liabilities of 円523.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MediciNova and its competitors. MediciNova's current Total Liabilities is 円523.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediciNova stock overvalued right now?
MediciNova (TSE:4875) has a current Total Liabilities of 円523.34 Mil. The current Total Liabilities is 円523.34 Mil. MediciNova's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For MediciNova (TSE:4875), the current Total Liabilities is 円523.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MediciNova Business Description

Other Exchanges MNOV:USA
Address 4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
28GF Score

Get the complete analysis for TSE:4875

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円213.00
Price